Small-Molecule Antibiotics & Resistance Inhibitors

Commercial sector

Small-Molecule Antibiotics & Resistance Inhibitors

Companies developing novel small-molecule antibacterial agents, including new antibiotic classes, beta-lactamase inhibitors (including metallo-beta-lactamase inhibitors), efflux pump inhibitors, and antibiotic potentiators/adjuvants intended for systemic treatment of drug-resistant bacterial infections.

Companies83
Commercial products251
Technology classes5
Countries17
Patents746

Profiled companies

Products
  • Shionogi logo
    Shionogi
    Japan3
  • Venatorx Pharmaceuticals logo
    Venatorx Pharmaceuticals
    United States4
  • Antabio logo
    Antabio
    France10
  • Arietis logo
    Arietis
    United States2
  • Basilea Pharmaceutica logo
    Basilea Pharmaceutica
    Switzerland4
  • BUGWORKS Research logo
    BUGWORKS Research
    India2

+ 77 more

← Back to what’s inside this report